Ipca Laboratories Limited Ipca Laboratories Limited

Ipca Laboratories Limited

IPCALAB

株式のランク #3415
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
株価
$20.00
時価総額
$5.08B
変化(1日)
-1.76%
変化(1年)
36.89%
国
IN
取引 Ipca Laboratories Limited (IPCALAB)

カテゴリー

Healthcare
Ipca Laboratories Limited(IPCALAB)のEPS
June 2026 時点のEPS TTM: $0.57
Ipca Laboratories Limitedの最新の財務報告と株価によると、同社の現在のEPS(TTM)は$0.57です。2024年末には、EPSは$0.26で、2023年のEPS$0.23と増加でした。
Ipca Laboratories LimitedのEPS履歴(2005から2026まで)
各年末時点のEPS
年 EPS 変化
2026 (TTM) $0.57 67.59%
2025 $0.34 31.43%
2024 $0.26 14.42%
2023 $0.23 -50.75%
2022 $0.46 -25.34%
2021 $0.61 93.12%
2020 $0.32 25.55%
2019 $0.25 73.94%
2018 $0.15 22.62%
2017 $0.12 113.46%
2016 $0.06 -65.49%
2015 $0.16 -48.97%
2014 $0.32 34.08%
2013 $0.24 8.86%
2012 $0.22 -7.87%
2011 $0.24 28.52%
2010 $0.18 131.65%
2009 $0.08 -41.78%
2008 $0.14 16.48%
2007 $0.12 111.05%
2006 $0.06 -18.58%
2005 $0.07 0.00%